CDRD, Canada’s national drug development and commercialization engine, is hosting a symposium “Novel strategies in cancer immunotherapy.”
Join us and top cancer researchers and clinicians from across Canada to learn about novel platforms in cancer immunotherapy research, implications for the discovery of therapeutic candidates, lessons learned, and to discuss how novel platforms may advance cancer immunotherapy R&D in Canada.
This event features a keynote address by Dr. Jason Berman, IWK Health Centre, additional concise talks, a moderated panel discussion and opportunities to network and explore potential partnerships and collaborations.
This event is free of charge but pre-registration is required: https://cdrd-immunotherapy.eventbrite.ca.
8:30 – 8:50am: Continental breakfast
8:45 – 9:00am: Welcoming remarks and brief overview of CDRD’s Immunotherapy Initiative
9:00 – 9:40am: Keynote: “The power of the fish for immunotherapy research” – Dr. Jason Berman (MSC Clinician Scientist in Pediatric Oncology, IWK Health Centre)
9:40 – 10:00am: Dr. Brad Nelson (Director and Distinguished Scientist, Deeley Research Centre, BC Cancer Agency)
10:00 – 10:20am: Dr. Rebecca Auer (Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute)
10:20 – 10:50am: Coffee break and networking
10:50 – 11:10am: Dr. Carl Hansen (CEO & President, AbCellera)
11:10 – 11:30am: Dr. Rob Holt (Head of Sequencing, Michael Smith Genome Sciences Centre, BC Cancer Agency)
11:30 – 11:50am: Dr. Thomas Kislinger (Senior Scientist, Princess Margaret Cancer Centre)
11:50am – 12:50pm: Moderated Panel Discussion, Q&A session
12:50 – 1:50pm: Networking lunch